View in EDS

Mutant KRAS inhibitors enter the scene of precision therapeutics for pancreatic cancer.

Saved in:
Bibliographic Details
Title: Mutant KRAS inhibitors enter the scene of precision therapeutics for pancreatic cancer.
Authors: Pollin G; The RASopathies Program, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Lomberk GA; The RASopathies Program, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Mathison AJ; The RASopathies Program, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Zimmermann MT; The RASopathies Program, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Urrutia R; The RASopathies Program, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Source: Journal of gastrointestinal oncology [J Gastrointest Oncol] 2024 Aug 31; Vol. 15 (4), pp. 1996-2001. Date of Electronic Publication: 2024 Aug 01.
Publication Type: Editorial; Comment
Journal Info: Publisher: AME Publishing Group Country of Publication: China NLM ID: 101557751 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2078-6891 (Print) Linking ISSN: 20786891 NLM ISO Abbreviation: J Gastrointest Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39279937
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mutant KRAS inhibitors enter the scene of precision therapeutics for pancreatic cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pollin+G%22">Pollin G</searchLink>; The RASopathies Program, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Lomberk+GA%22">Lomberk GA</searchLink>; The RASopathies Program, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Mathison+AJ%22">Mathison AJ</searchLink>; The RASopathies Program, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Zimmermann+MT%22">Zimmermann MT</searchLink>; The RASopathies Program, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Urrutia+R%22">Urrutia R</searchLink>; The RASopathies Program, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101557751%22">Journal of gastrointestinal oncology</searchLink> [J Gastrointest Oncol] 2024 Aug 31; Vol. 15 (4), pp. 1996-2001. <i>Date of Electronic Publication: </i>2024 Aug 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Editorial; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22AME+Publishing+Group%22">AME Publishing Group </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101557751 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2078-6891 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220786891%22">20786891 </searchLink><i>NLM ISO Abbreviation: </i>J Gastrointest Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39279937
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.21037/jgo-24-326
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1996
    Titles:
      – TitleFull: Mutant KRAS inhibitors enter the scene of precision therapeutics for pancreatic cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pollin G
      – PersonEntity:
          Name:
            NameFull: Lomberk GA
      – PersonEntity:
          Name:
            NameFull: Mathison AJ
      – PersonEntity:
          Name:
            NameFull: Zimmermann MT
      – PersonEntity:
          Name:
            NameFull: Urrutia R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 08
              Text: 2024 Aug 31
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2078-6891
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Journal of gastrointestinal oncology
              Type: main
ResultId 1